
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
>If you're looking up melanoma information on the Internet, be sure todouble-check your finding with your doctor, says a new study from the Journalof Clinical Oncology.